Comment from North Star ALS

Summary: North Star ALS, a nonprofit organization representing families affected by ALS, strongly supports the finalization of the FDA's draft guidance on the plausible mechanism framework. They argue that this framework is essential for developing sustainable, individualized therapies for ultra-rare genetic mutations and request that the FDA clarify its eligibility for biomarker-defined subgroups of sporadic ALS.